Penn Neurosurgery

Penn Neurosurgery

Wednesday, December 10, 2014

Penn Research Offers Hope of Finding Concussion Marker

Robert Siman, PhD
Robert Siman, PhD
A new study from Penn Medicine neuroscientists found that a blood protein called SNTF has promise as a biomarker for sports-related concussion, reports the Philadelphia Inquirer. Led by Robert Siman, PhD, an associate professor of Neurosurgery, the team found that SNTF surged and stayed elevated in professional hockey players with persistent concussion symptoms, but not in players who recovered.

"A protein like this [SNTF] is so desperately needed,” Siman told the Inquirer. “We need a way to pull athletes out of a game, prick their finger, and not even ask them their symptoms. We need to take the guesswork out of diagnosing concussion."

Continue Reading

Wednesday, October 1, 2014

Penn Proud to Serve as Flagship Sponsor for Race for Hope

Now entering its ninth year, the National Brain Tumor Society's Race for Hope is a 5K Run/Walk fundraiser to support the brain tumor community. The Race for Hope is a way to reach other families, patients and survivors affected by brain tumors.

Penn Neurosurgery
Penn Neurosurgery is proud to once again serve as a flagship sponsor for this year's Philadelphia Race for Hope to be held on Sunday, November 2.

Learn how you can help the fight against brain tumors by either donating to the team or joining the race by visiting the Penn Pioneers page on the Race for Hope website.

Race for Hope - Event Details
Date: November 2, 2014
Location: Philadelphia Art Museum
Race/walk starts: 8:30 a.m.

About the National Brain Tumor Society

The National Brain Tumor Society is the largest nonprofit dedicated to the brain tumor community in the United States. It is "fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and those who will be diagnosed tomorrow."

Brain Tumor Facts

  • Nearly 700,000 people in the United States are living with a primary brain tumor.
  • In 2014, an estimated 69,000 new primary brain tumor diagnoses will be made in the U.S.
  • About 120 types of brain and CNS tumors have been identified to date and some have multiple subtypes. Each tumor type/subtype is genetically distinct, making the search for treatments or a cure extremely difficult.
Learn more about the treatment options at the Penn Brain Tumor Center by downloading the free patient education guide.

Tuesday, September 16, 2014

Isaac Chen, MD, Joins Penn Neurosurgery

Penn Neurosurgery
H. Isaac Chen, MD, has joined Penn Neurosurgery as an Assistant Professor.

Dr. Chen received his undergraduate degree in biochemical sciences from Harvard University; subsequently, he received his medical degree from the University of Pennsylvania. He then completed an internship in general surgery and his residency in neurosurgery at the University of Pennsylvania.

Dr. Chen’s clinical interests include the surgical management of tumors in eloquent brain areas, post-traumatic epilepsy, and traumatic brain injury. His laboratory research focuses on developing novel strategies for repairing brain damage using a combination of stem cell biology, tissue engineering, and neural-electric interfaces.

Dr. Chen is also engaged in research efforts to improve intraoperative brain mapping and to understand brain plasticity after brain injury.

Dr Chen is board certified in neurological surgery. He sees patients at Penn Medicine University City, a facility of Penn Presbyterian Medical Center.

Penn Neurosurgery Welcomes Ali K. Ozturk, MD

Penn NeurosurgeryAli K. Ozturk, MD, has joined Penn Neurosurgery as an Assistant Professor.

Dr Ozturk  received his BA in biology from Johns Hopkins University and his medical degree from the Yale University School of Medicine. He then completed a residency in neurosurgery at Yale-New Haven Hospital, and a fellowship in spine surgery at the Johns Hopkins Hospital.

Dr. Ozturk specializes in the treatment of brain tumors, brain trauma, and complex spinal disorders, including tumors, degenerative spine disease, trauma, and minimally invasive spine surgery.

His research efforts focus on spinal disease, including degenerative and oncologic disease processes and the genetic basis of diseases affecting the central nervous system. He has published extensively on the genetic basis of human disease and his work in this field has earned him numerous awards and grants from the Congress of Neurological Surgeons (CNS) and the American Association of Neurological Surgeons (AANS).

Dr. Ozturk is board certified in neurological surgery. He sees patients at Pennsylvania Hospital.

Thursday, August 14, 2014

Penn Neurosurgery Welcomes David K. Kung, MD

David K. Kung, MD
David K. Kung, MD, joins Penn Medicine as the newest member of the Penn neurovascular team. Dr. Kung obtained his undergraduate degree in neuroscience and biochemistry graduating with honors from the University of Washington. He then attended the Albert Einstein College of Medicine in New York and completed his neurosurgical training at the University of Iowa. Dr. Kung went on to complete a neurovascular surgery and endovascular neurosurgery fellowship at the Thomas Jefferson University.

Dr. Kung has a specific clinical interest in neurovascular diseases and provides a full spectrum of treatments using microsurgical, radiosurgical, and endovascular techniques. In addition, Dr. Kung is deeply interested in neurovascular research and has over 25 peer-reviewed articles published. He is actively engaged in the study of cerebral aneurysms including its mechanisms of growth and rupture, as well as novel treatments.

Dr. Kung sees patients at the Hospital of the University of Pennsylvania. To schedule an appointment, please call 800-789-PENN (7366) or request an appointment online.

Thursday, July 17, 2014

U.S. News & World Report Names Penn Neurosurgery Best in Region

For the 24th consecutive year, Penn Neurosurgery has been ranked as best in the Philadelphia region, according to the U.S. News & World Report rankings released earlier this month. The specialty was also ranked 9th in the nation.

Top Neurosurgery Department in Region
In addition, the Hospitals of the University of Pennsylvania-Penn Presbyterian (HUP/PPMC) are ranked among the top hospitals in the United States by U.S. News & World Report. The publication's prestigious annual ranking of hospitals placed HUP/PPMC 7th in its "Honor Roll", in recognition for excellence in multiple specialties. HUP/PPMC also ranks #1 in the region, while Pennsylvania Hospital (PAH) is ranked 6th in the region.

One of the first neurosurgery programs in the country, Penn Neurosurgery is known for providing comprehensive surgical management of disorders of the brain, spinal cord and peripheral nervous system. Penn Medicine is committed to translating cutting edge research into improved patient care.

Neurosurgeons at Penn Medicine perform thousands of procedures annually, many of them reflecting a rising trend towards complex procedures - requiring both surgical expertise and technical innovation. Patients benefit from that experience, skill and multidisciplinary approach, to achieve the best possible outcomes.

How the Rankings are Determined

To create the 2014-15 rankings, U.S. News & World Report looked at data from nearly 5,000 hospitals and surveyed more than 9,500 physicians. Death rates, patient safety and hospital reputation are a few of the many factors considered. 144 hospitals were nationally ranked in a specialty. The Honor Roll features 17 of the Best Hospitals that scored near the top in at least six specialties.

Read more about the U.S. News & World Report 2014-15 Best Hospital Rankings

Thursday, July 10, 2014

Penn Neurosurgeon Leading the Way to Improve Memory

Deep Brain Stimulation for Parkinson's
Gordon Baltuch, MD
Steve Zabielski, who is battling Parkinson’s Disease, was having a difficult time managing his disease until Penn neurosurgeon, Gordon Baltuch, MD, a member of the research team, implanted a stimulator and electrodes in his brain to help restore his mobility. Since getting the implant he can now move, eat, sleep, exercise and do many things he could not before.

Researchers hope the same technology can be used to develop a new implantable device to help improve memory- starting with patients like Steve who already have electrodes implanted in the brain. Their goal is to eventually provide memory loss treatment for veterans and others with neurological disorders.

Watch the full CBS3 segment.

Learn More About Steve's Journey: From Parkinson's to a Nearly Normal Life